Biopharmaceuticals.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
JOHN MICHAEL GONZALEZ COREY MALMGREN TIMOTHY ROBINSON JONATHON JONES BRYANT HALL JOHN KIRKLAND TWOMEY